News Briefs

Atsena Therapeutics rakes in $55m Series A

Atsena Therapeutics, a clinical-stage gene therapy company, has secured $55 million in Series A financing.

16 December 2020

Atsena Therapeutics, a clinical-stage gene therapy company, has secured $55 million in Series A financing. Sofinnova Investments led the round.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now